BancorpSouth’s BioMarin Pharmaceuticals BMRN Stock Holding History

BancorpSouth’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$254K	Buy	2,732 +35	+1%	+$3.09K	0.03%	213
2017 Q2	$245K	Hold	2,697	–	–	0.02%	200
2017 Q1	$237K	Hold	2,697	–	–	0.02%	209
2016 Q4	$223K	Hold	2,697	–	–	0.02%	200
2016 Q3	$250K	Hold	2,697	–	–	0.03%	196
2016 Q2	$210K	Hold	2,697	–	–	0.02%	214
2016 Q1	$222K	Sell	2,697 -1,916	-42%	-$156K	0.03%	215
2015 Q4	$483K	Sell	4,613 -2,047	-31%	-$214K	0.06%	134
2015 Q3	$701K	Sell	6,660 -157	-2%	-$21K	0.09%	110
2015 Q2	$932K	Sell	6,817 -300	-4%	-$37.2K	0.1%	95
2015 Q1	$887K	Sell	7,117 -1,917	-21%	-$203K	0.1%	97
2014 Q4	$817K	Hold	9,034	–	–	0.09%	104
2014 Q3	$652K	Buy	9,034 +2,148	+31%	+$141K	0.07%	119
2014 Q2	$428K	Buy	6,886 +574	+9%	+$34.7K	0.04%	155
2014 Q1	$431K	Buy	+6,312	New	+$465K	0.05%	164

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BancorpSouth's BMRN Position: Q3 2017 in Review

BancorpSouth increased its BioMarin Pharmaceuticals (BMRN) stake by 1.3% in Q3 2017, buying an estimated $3.09K and bringing the position to 2,732 shares worth $254K. The position accounts for 0.03% of the portfolio, ranked #213.

BancorpSouth first reported a position in BMRN in Q1 2014 and has held it in 15 quarters since. The position peaked at $932K in Q2 2015. 411 funds tracked by Wall St. Rank hold BMRN as of Q3 2017.

BancorpSouth held 2,732 shares of BioMarin Pharmaceuticals worth $254K as of Q3 2017.
BancorpSouth bought 35 BioMarin Pharmaceuticals shares in Q3 2017, an estimated $3.09K.
BioMarin Pharmaceuticals made up 0.03% of BancorpSouth's portfolio in Q3 2017, its #213 holding.
BancorpSouth first reported a position in BioMarin Pharmaceuticals in Q1 2014 and has held it in 15 quarters since.
BancorpSouth's BioMarin Pharmaceuticals position peaked at $932K in Q2 2015.
411 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2017.

Based on BancorpSouth's 13F filing for Q3 2017, filed 14 Nov 2017.